A randomized phase II study of weekly paclitaxel with or without pelareorep in patients with metastatic breast cancer: final analysis of Canadian Cancer Trials Group IND.213.

Overview of attention for article published in Breast Cancer Research and Treatment, October 2017

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#17 of 4,815)
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news: 50 news outlets

twitter: 1 X user

Citations

dimensions_citation: 74 Dimensions

Readers on

mendeley: 103 Mendeley

Summary News X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 24,784 followers.

The reovirus work of $oncy is very interesting ...here is a older clinical trial that they did ...showed improvement in overall survival in #breastcancer We wish Oncolytics the best of luck in their new trials https://t.co/PWzESyqgPf

29 Jan 2023

Reply Repost Favourite